Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 6, 2006, Pages 577-583

  Kersnik, J ^a,c   Peklar, J ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b National Health Insurance Institute   (Slovenia)

^c NONE   (Slovenia)

Author keywords

Cost control; Drug costs; Drug prescribing; Family practice; Primary care; Quality of health care; Southern Europe

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; BUDGET; DATA BASE; DRUG COST; DRUG INDUSTRY; DRUG QUALITY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH SURVEY; HUMAN; INTERNATIONAL COOPERATION; LEGAL LIABILITY; MALE; MEDICAL PRACTICE; MEDICAL RESEARCH; NATIONAL HEALTH INSURANCE; NORMAL HUMAN; PHYSICIAN ATTITUDE; POSTAL MAIL; PRESCRIPTION; PUBLIC HEALTH SERVICE; SLOVENIA;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG; SLOVENIA;

EID: 33751370626     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00776.x     Document Type: Article

References (30)

1. Zdravstveni statisticni letopis 2001 (2002) Yearly health report 2001 - Slovene. Zdrav Vars, 40 (Suppl.), 13-16.
2. Muijrers PEM, Janknegt R, Sijbrandij J et al. (2004) Prescribing indicators. European Journal of Clinical Pharmacology, 60, 739-746.
3. Svab I, Petek-Ster M, Kersnik J, Zivcec-Kalan G, Car J (2005) A cross sectional study of performance of Slovene general practitioners (Slovene). Zdrav Var, 44, 183-192.
4. Morgan SG (2002) Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan. Health Services Research, 37, 1243-1266.
5. Mukamal KJ, Markson LJ, Flier SR, Calabrese D (2002) Restocking the sample closet: results of a trial to alter medication prescribing. Journal of the American Board of Family Practice, 15, 285-289.
6. Hellerstein JK (1998) The importance of the physician in the generic versus trade-name prescription decision. The Rand Journal of Economics, 29, 108-136.
7. Stewart-Brown S, Surender R, Bradlow J, Coulter A, Doll H (1995) The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme. BMJ, 311, 1543-1547.
8. Mintzes B, Barer ML, Kravitz RL et al. (2003) How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ, 169, 405-412.
9. Hollis A (2002) The importance of being first: evidence from Canadian generic pharmaceuticals. Health Economics, 11, 723-734.
10. Gill PS, Roalfe A (2001) Determinants of prescribing costs amongst single-handed general practitioners. Journal of Clinical Pharmacy and Therapeutics, 26, 433-435.
11. Joyce GF, Escarce JJ, Solomon MD, Goldman DP (2002) Employer drug benefit plans and spending on prescription drugs. JAMA, 288, 1733-1739.
12. McManus P, Birkett DJ, Dudley J, Stevens A (2001) Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. Pharmacoepidemiology and Drug Safety, 10, 295-300.
13. Himmel W, Kron M, Thies-Zajonc S, Kochen MM (1997) Changes in drug prescribing under the Public Health Reform Law-a survey of general practitioners' attitudes in East and West Germany. International Journal of Clinical Pharmacology and Therapeutics, 35, 164-169.
14. Bloor K, Freemantle N (1996) Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. BMJ, 312, 1525-1527.
15. Ashworth M, Golding S, Majeed A (2002) Prescribing indicators and their use by primary care groups to influence prescribing. Journal of Clinical Pharmacy and Therapeutics, 27, 197-204.
16. Williams D, Bennett K, Feely J (2005) The application of prescribing indicators to a primary care prescription database in Ireland. European Journal of Clinical Pharmacology, 61, 127-133.
17. Vallano A, Montané E, Arnau JM et al. (2004) Medical speciality and pattern of medicines prescription. European Journal of Clinical Pharmacology, 60, 725-730.
18. Walker J, Mathers N (2002) The impact of a general practice group intervention on prescribing costs and patterns. Br J Gen Prac, 52, 181-186.
19. Dormuth CR, Maclure M, Basset K et al. (2004) Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomised trial. CMAJ, 171, 1057-1061.
20. Soumerai SB, Avorn J (1990) Principles of education outreach (academic detailing) to improve clinical decision making. JAMA, 253, 549-556.
21. Rasmussen HMS, Søndergaard J, Kampmann JP, Andersen M (2005) General practitioners prefer prescribing indicators based on detailed information on individual patients: a Delphy study. European Journal of Clinical Pharmacology, 61, 237-241.
22. Anonymous (2005) Essential medicines - Definition. World Health Organisation. http://www.who.int/medicines/services/essmedicines_def/en/ (accessed on 10 October 2006).
23. Sales MM, Cunningham FE, Glassman PA, Valentino MA, Good CB (2005) Pharmacy benefits management in the Veterans Health Administration 1995 to 2003. The American Journal of Managed Care, 11, 104-112.
24. Anonymous (2002) Health plans keeping drug cost increases in check with programs that promote generics. Capitation Management Report, 9, 97.
25. Wensing M, Broge B, Kaufmann-Kolle P, Andres E, Szecsenyi J (2004) Quality circles to improve prescribing patterns in primary medical care: what is their actual impact? Journal of Evaluation in Clinical Practice, 10, 457-466.
26. Garcia AJ, Martos F, Leiva F et al. (2003) Genéricos: Buenos o malos? Conocimientos y actitudes de los medicos ante los medicamentos genéricos. Gaceta Sanitaria, 17, 144-149.
27. Torralba Guirao M, Gilabert Perramon A, Pelaez de Lono J et al. (2000) Implantacion de medicamentos genericos (EFG) en Espana y Cataluna: posibilidades de ahorro. Atencion Primaria, 26, 210-215.
28. McGettigan P, McManus J, O'Shea B, Chan R, Feely J (1997) Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns. Irish Medical Journal, 90, 146-147.
29. Mott DA, Cline RR (2002) Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care, 40, 662-674.
30. Mamdani MM, Tu K, Austin PC, Alter DA (2002) Influence of socioeconomic status on drug selection for the elderly in Canada. Annals of Pharmacotherapy, 36, 804-808.